Select Medical Holdings Corporation
Symboli: SEM
NYSE
33.23
USDMarkkinahinta tänään
15.2674
P/E-suhde
-0.1594
PEG-suhde
4.32B
MRK Cap
- 0.02%
DIV Tuotto
Select Medical Holdings Corporation (SEM) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 143 | 97.9 | 74.3 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 59 | 74.9 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 940.3 | 941.3 | 889.3 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 22.7 | -74.9 | 0 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 151.6 | 232.1 | 175.8 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1257.6 | 1271.3 | 1139.4 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2212.2 | 2171.2 | 2040.2 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 3513.2 | 3484.2 | 3448.9 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 329.9 | 351.7 | 374.9 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3843.1 | 3835.9 | 3823.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 316 | 45.2 | 18.1 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 21.1 | 0 | -18.1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 39.6 | 341.7 | 356.7 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 6432 | 6394 | 6220.7 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 7689.6 | 7665.3 | 7360.2 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 174.3 | 186.7 | 233.8 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 346 | 281.1 | 246.9 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 1.5 | 0.5 | 1.4 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4613.5 | 4843.6 | 4472.9 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 39 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 735.7 | 687.3 | 708.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 4867.2 | 5153.6 | 4761.2 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1271.3 | 1245.2 | 1145.9 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 6115.6 | 6308.7 | 6034.3 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 751.9 | 581 | 593.3 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 42.9 | 88.6 | 12.3 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 493.4 | 647.8 | 720.2 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1288.3 | 1317.5 | 1325.9 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7689.6 | 7894.9 | 7360.2 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 285.7 | 268.7 | 255 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1574 | 1586.2 | 1580.9 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 59 | 120.1 | 18.1 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 4959.5 | 5124.7 | 4719.8 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 4875.5 | 5026.8 | 4645.5 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 299.7 | 198 | 499.9 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 208.7 | 205.8 | 202.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -16.1 | 7.5 | 5.1 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 43.8 | 37.8 | 30.9 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 59.5 | -159.5 | -330 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | 1.2 | -52.2 | 23.1 | |||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | -82.8 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -6.4 | -48 | 53.4 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 64.8 | -59.3 | -323.7 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -13.6 | -4.8 | -7.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -229.2 | -190.4 | -180.5 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -39.4 | -44.3 | -102.9 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 8.3 | 26.8 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -268.5 | -226.3 | -256.6 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -3232.6 | -870.6 | -39.7 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3028.6 | 0 | 235.4 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -12.8 | -195.5 | -79.5 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -63.9 | -64.6 | -50.6 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -46.9 | 1095.8 | -713 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -327.5 | -34.9 | -647.4 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -13.9 | 23.6 | -502.8 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 84 | 97.9 | 74.3 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 97.9 | 74.3 | 577.1 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 582.1 | 284.8 | 401.2 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -229.2 | -190.4 | -180.5 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 352.9 | 94.5 | 220.7 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 6664.1 | 6333.5 | 6204.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 5732 | 5600.2 | 5285.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 932 | 733.4 | 919.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 177.1 | 58.6 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 377.2 | 330.1 | 205.6 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 6109.2 | 5930.3 | 5490.7 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 169.1 | 5.3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 198.6 | 169.1 | 136 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 26.1 | -142.7 | -84.1 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 177.1 | 58.6 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 26.1 | -142.7 | -84.1 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 198.6 | 169.1 | 136 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 208.7 | 232.2 | 252.4 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 554.9 | 403.3 | 713.8 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 382.4 | 260.6 | 629.7 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 82.6 | 62.6 | 129.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 243.5 | 159 | 402.2 |
Usein kysytty kysymys
Mikä on Select Medical Holdings Corporation (SEM) taseen loppusumma?
Select Medical Holdings Corporation (SEM) kokonaisvarat ovat 7689631000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.136.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 1.947.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.040.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.069.
Mikä on Select Medical Holdings Corporation (SEM) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 243491000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 4959545000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 377167000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.